This inventor holds 4 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2006-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2009
Title: Spotlight on Hans Peter Marty: Innovator in Pharmaceuticals
Introduction: Hans Peter Marty is a prolific inventor hailing from Basel, Switzerland, with a notable track record of four patents in the pharmaceutical industry.
Latest Patents: Marty's recent patents include cutting-edge compounds such as CB 1 receptor inverse agonists for the treatment of diseases linked to CB1 receptors and aminocycloalkanes as DPP-IV inhibitors for conditions like diabetes.
Career Highlights: Currently employed at Hoffmann-La Roche Inc., one of the leading pharmaceutical companies globally, Marty continues to make significant contributions to the field.
Collaborations: Within his workplace, Marty collaborates closely with esteemed colleagues like Robert Narquizian and Alexander Mayweg, paving the way for innovative discoveries in pharmaceuticals.
Conclusion: Hans Peter Marty's inventive spirit and dedication to advancing pharmaceutical research highlight his invaluable contributions to the industry, making him a key figure in the realm of medical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile